)
Barkha Mathur leads health coverage for the Business Standard website. She reports on the intersection of medicine, policy, and health science, with a focus on stories that impact readers’ physical and mental well-being. When not tracking the latest developments in health, she’s often reading medical research or listening to hip-hop.
Barkha Mathur leads health coverage for the Business Standard website. She reports on the intersection of medicine, policy, and health science, with a focus on stories that impact readers’ physical and mental well-being. When not tracking the latest developments in health, she’s often reading medical research or listening to hip-hop.
Grasim Q4 results: The board recommended dividend of Rs 10 per equity share for FY24
ONGC's board has recommended final dividend at the rate of Rs 2.50 per equity share of face value
The BEL board has recommended a final dividend of Rs 0.80 per share for FY24 subject to approval by shareholders
The Oil India board has recommended an issue of bonus shares in a 1:2 ratio, subject to the approval of shareholders
PM Modi has declared Rs 52,920 in cash and fixed deposits worth Rs 2.85 cr, according to the election affidavit
It allocated over 43 million equity shares at Rs 272 per share on Tuesday, to anchor investors
He was diagnosed with cancer in April this year
Bill and Melinda Gates Foundation will change its name to Gates Foundation after French Gates' departure
CBDT has released new functionality in AIS for taxpayers to display the status of the information confirmation process in real-time
NGO Population Foundation of India raises concerns over misinterpretation; advocates for contextual understanding of demographic trends
As the temperature in India soars, so does the demand for cooling essentials
TVS Motor Q4 result: The company's revenue from operations jumped to Rs 10,042 crore in Q4FY24 compared with Rs 8,031 crore in the fourth quarter of FY23
Serum Institute of India says it stopped manufacturing Covishield since December 2021
The special live trading session will have intra-day switch over from primary site to disaster recovery site
'Our US sales remain healthy driven by inhalation products, and our India formulation business is delivering ahead of market,' said Nilesh Gupta, MDirector, Lupin
DMart Q4 results: The revenue from operations of DMart rose to Rs 12,726.5 crore in Q4FY24 from Rs 10,594 crore in the same quarter of previous financial year
He was among the initial whistleblowers who raised concerns about the oversight of manufacturing defects in the 737 Max by Spirit's leadership
Fed holds rates steady, flags 'lack of further progress' on inflation
Adani portfolio of companies will continue to provide innovative, reliable, and scalable solutions to support the nation's economic growth, says Gautam Adani
AstraZeneca's acknowledgment that the vaccine may lead to thrombosis isn't a new revelation, but it underscores the need for transparent communication by the pharma companies, say experts